Auteur(s)
Présentation
After decades of descriptive studies, the biology of cancer is undergoing a real revolution: with genetic approaches, researchers have identified many of the cell deregulations likely to drive tumours. A treatment combining arsenic and retinoic acid targets the protein responsible for promyelocytic leukaemia. This treatment, which has cured virtually all patients, gives hope that the in-depth understanding of carcinogenesis mechanisms may lead to new therapeutic approaches that could be transposed to other cancers.
Hugues de Thé, a physician and former intern at the Hôpitaux de Paris, with a PhD in science, is head of the biochemistry/molecular biology service at the Hôpital Saint-Louis, head of the research unit UMR “Pathologie et virologie moléculaire” and professor of molecular biology at the Paris-Diderot University. He has been a member of the French Academy of Sciences since 2011 and, in March 2014, was appointed Professor at the Collège de France, where he holds the Chair of Cellular and Molecular Oncology.
Sommaire
Serge Haroche : Introduction
Hugues de Thé : Oncology: From Empiricism to Integrative Biology
Du même auteur
Toutes les publications du même auteur
Hugues de Thé
L'oncologie : de l'empirisme à la biologie intégrée
Dans la même collection
Toutes les publications dans la collection
Nathalie Bajos
La production sociale des inégalités de santé
Lea Ypi
L’idée de socialisme moral
Maria Melchior
Santé mentale et addictions : de l'intime au populationnel
François-Marie Bréon
Le cycle perturbé du carbone